Form 4: Allovir Inc. Chief Accounting Officer Brett R. Hagen Reports Sale of Common Stock to Cover Tax Obligations

Sentiment:

SEC Form 4 Filing


Brett R. Hagen, Chief Accounting Officer of Allovir, Inc., reports the sale of 1,597 shares of common stock on May 3, 2024, to cover tax withholding obligations related to vesting restricted stock units.

Summary

  • On May 3, 2024, Brett R. Hagen, the Chief Accounting Officer of Allovir, Inc., sold 1,597 shares of common stock.
  • The sale was executed to cover tax withholding obligations associated with the vesting of restricted stock units.
  • The shares were sold at a weighted average price of $0.796, with individual transactions ranging from $0.7801 to $0.8098.
  • Following the transaction, Hagen directly owns 76,022 shares of Allovir, Inc. common stock.

Sentiment

Score: 5

Explanation: The sentiment is neutral as the filing relates to a routine transaction for tax purposes and doesn't indicate any strategic shift or concern.

Industry Context

Form 4 filings are a routine part of regulatory compliance for corporate insiders, providing transparency into their transactions in company stock. This particular filing reflects a sale to cover tax obligations, which is a common occurrence.

Key Dates

DateDescription
05/03/2024Date of transaction: Sale of common stock.
05/07/2024Date of signature on the Form 4 filing.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.